Erratum: Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
Unknown authors
Topics & Concepts
DurvalumabMedicinePaclitaxelOlaparibCarboplatinOncologyEndometrial cancerInternal medicineCancerCisplatinChemotherapyNivolumabImmunotherapyPoly ADP ribose polymerasePolymeraseBiochemistryChemistryGenePARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentEndometrial and Cervical Cancer Treatments